Paul J. DeSchepper

503 total citations
8 papers, 396 citations indexed

About

Paul J. DeSchepper is a scholar working on Pharmacology, Surgery and Physiology. According to data from OpenAlex, Paul J. DeSchepper has authored 8 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 2 papers in Surgery and 2 papers in Physiology. Recurrent topics in Paul J. DeSchepper's work include Inflammatory mediators and NSAID effects (2 papers), Cancer therapeutics and mechanisms (1 paper) and Pharmacology and Obesity Treatment (1 paper). Paul J. DeSchepper is often cited by papers focused on Inflammatory mediators and NSAID effects (2 papers), Cancer therapeutics and mechanisms (1 paper) and Pharmacology and Obesity Treatment (1 paper). Paul J. DeSchepper collaborates with scholars based in United States, Belgium and Canada. Paul J. DeSchepper's co-authors include Denis Riendeau, Elliot Ehrich, James R. Seibold, Arturo G. Porras, Wei Yuan, Johanna Wittreich, Luc J. Debeer, G P Mannaerts, A. Buntinx and Samuel P. Bessman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Kidney International.

In The Last Decade

Paul J. DeSchepper

8 papers receiving 371 citations

Peers

Paul J. DeSchepper

PHARM

SURGE

BIOCH

PHARM

PHYSI

Helen Stead United Kingdom

Peggy Wong United States

Maria Antonietta Satta Italy

Mary Dixon United States

Tai‐Juan Aw Australia

F. B. Ubatuba United Kingdom

P. A. Kot United States

M.C. Carrara Canada

Tomasz A. Swierkosz United Kingdom

V. Tamassia Italy

Helen Stead United Kingdom

Paul J. DeSchepper

506 ×1.9

PHARM

234 ×2.4

SURGE

54 ×0.7

BIOCH

60 ×0.9

PHARM

62 ×1.0

PHYSI

Citations per year, relative to Paul J. DeSchepper Paul J. DeSchepper (= 1×) peers Helen Stead

Countries citing papers authored by Paul J. DeSchepper

Since Specialization

Citations

This map shows the geographic impact of Paul J. DeSchepper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. DeSchepper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. DeSchepper more than expected).

Fields of papers citing papers by Paul J. DeSchepper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. DeSchepper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. DeSchepper. The network helps show where Paul J. DeSchepper may publish in the future.

Co-authorship network of co-authors of Paul J. DeSchepper

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. DeSchepper. A scholar is included among the top collaborators of Paul J. DeSchepper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. DeSchepper. Paul J. DeSchepper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Feinstein, Alvan R., Lothar Heinemann, Gary C. Curhan, et al.. (2000). Relationship between nonphenacetin combined analgesics and nephropathy: A review. Kidney International. 58(6). 2259–2264. 39 indexed citations

2.

Ehrich, Elliot, Denis Riendeau, Wei Yuan, et al.. (1999). Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clinical Pharmacology & Therapeutics. 65(3). 336–347. 265 indexed citations

3.

Ehrich, Elliot, D Hilliard, Arturo G. Porras, et al.. (1999). Demonstration of specific COX-2 inhibition by MK-966 in humans with supratherapeutic doses. Clinical Pharmacology & Therapeutics. 65(2). 164–164. 6 indexed citations

4.

Depré, Marleen, Beth S. Friedman, Wesley Tanaka, et al.. (1993). Biochemical activity, pharmacokinetics, and tolerability of MK-886, a leukotriene biosynthesis inhibitor, in humans. Clinical Pharmacology & Therapeutics. 53(5). 602–607. 18 indexed citations

5.

Stockmans, Filip, et al.. (1991). TCV-309 - A NOVEL PAF-ANTAGONIST, INHIBITS PAF-INDUCED HUMAN PLATELET-AGGREGATION EXVIVO. Thrombosis and Haemostasis. 65(6). 1108–1108. 1 indexed citations

6.

Tobert, Jonathan A., Paul J. DeSchepper, T. B. Tjandramaga, et al.. (1981). Effect of antacids on the bioavailability of diflunisal in the fasting and postprandial states. Clinical Pharmacology & Therapeutics. 30(3). 385–389. 24 indexed citations

7.

Debeer, Luc J., et al.. (1977). Effect of sulfonylureas on triglyceride metabolism in the rat liver: possible role of the lysosomes in hepatic lipolysis.. Journal of Clinical Investigation. 59(2). 185–192. 30 indexed citations

8.

DeSchepper, Paul J., et al.. (1965). A Requirement for Carbohydrate Metabolism for the Stimulation of Amino Acid Incorporation into Protein by Insulin. Journal of Biological Chemistry. 240(4). 1670–1674. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact